Global Aortic Stenosis Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Aortic Stenosis Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Aortic stenosis is a valvular heart disease with varying severity. Narrowed valve openings of the large blood vessel aorta reduce blow flow making the heart pump excessively. Poor prognosis with a fatal mortality rate is observed in severe cases. In-time diagnosis and treatment are of significant importance.
Aortic Stenosis report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Aortic Stenosis market is projected to reach US$ 10620 million in 2033, increasing from US$ 5398 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2033. Demand from Congenital Aortic Stenosis and Acquired Aortic Stenosis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Aortic Stenosis industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Aortic Stenosis key companies include Abbott Laboratories, AstraZeneca Plc., Boston Scientific Corporation, Coroneo, CryoLife, Inc., Edwards Lifesciences Corporation, JenaValve Technology, Inc., LifeNet Health and LivaNova PLC, etc. Abbott Laboratories, AstraZeneca Plc., Boston Scientific Corporation are top 3 players and held % share in total in 2022.
Aortic Stenosis can be divided into Transcatheter Aortic Valve Implantation (TAVI) and Surgical Aortic Valve Replacement (SAVR), etc. Transcatheter Aortic Valve Implantation (TAVI) is the mainstream product in the market, accounting for % share globally in 2022.
Aortic Stenosis is widely used in various fields, such as Congenital Aortic Stenosis and Acquired Aortic Stenosis, etc. Congenital Aortic Stenosis provides greatest supports to the Aortic Stenosis industry development. In 2022, global % share of Aortic Stenosis went into Congenital Aortic Stenosis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Aortic Stenosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Abbott Laboratories
AstraZeneca Plc.
Boston Scientific Corporation
Coroneo
CryoLife, Inc.
Edwards Lifesciences Corporation
JenaValve Technology, Inc.
LifeNet Health
LivaNova PLC
Medtronic Plc
Meril Life Sciences Pvt. Ltd.
Thubrikar Aortic Valve
Segment by Type
Transcatheter Aortic Valve Implantation (TAVI)
Surgical Aortic Valve Replacement (SAVR)
Congenital Aortic Stenosis
Acquired Aortic Stenosis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Aortic Stenosis market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Aortic Stenosis introduction, etc. Aortic Stenosis Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Aortic Stenosis market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Aortic Stenosis report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Aortic Stenosis market is projected to reach US$ 10620 million in 2033, increasing from US$ 5398 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2033. Demand from Congenital Aortic Stenosis and Acquired Aortic Stenosis are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Aortic Stenosis industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Aortic Stenosis key companies include Abbott Laboratories, AstraZeneca Plc., Boston Scientific Corporation, Coroneo, CryoLife, Inc., Edwards Lifesciences Corporation, JenaValve Technology, Inc., LifeNet Health and LivaNova PLC, etc. Abbott Laboratories, AstraZeneca Plc., Boston Scientific Corporation are top 3 players and held % share in total in 2022.
Aortic Stenosis can be divided into Transcatheter Aortic Valve Implantation (TAVI) and Surgical Aortic Valve Replacement (SAVR), etc. Transcatheter Aortic Valve Implantation (TAVI) is the mainstream product in the market, accounting for % share globally in 2022.
Aortic Stenosis is widely used in various fields, such as Congenital Aortic Stenosis and Acquired Aortic Stenosis, etc. Congenital Aortic Stenosis provides greatest supports to the Aortic Stenosis industry development. In 2022, global % share of Aortic Stenosis went into Congenital Aortic Stenosis filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Aortic Stenosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Abbott Laboratories
AstraZeneca Plc.
Boston Scientific Corporation
Coroneo
CryoLife, Inc.
Edwards Lifesciences Corporation
JenaValve Technology, Inc.
LifeNet Health
LivaNova PLC
Medtronic Plc
Meril Life Sciences Pvt. Ltd.
Thubrikar Aortic Valve
Segment by Type
Transcatheter Aortic Valve Implantation (TAVI)
Surgical Aortic Valve Replacement (SAVR)
Segment by Application
Congenital Aortic Stenosis
Acquired Aortic Stenosis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Aortic Stenosis market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Aortic Stenosis introduction, etc. Aortic Stenosis Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Aortic Stenosis market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.